CAS 114567-47-4: Ganoderiol F

Ganoderiol F is a bioactive compound that exhibits anticancer activity by inhibiting protein synthesis and cell division. It has been shown to inhibit the growth of cancer cells in vitro through receptor binding and inhibition of protein synthesis, leading to cell death. Ganoderiol F also inhibits the complement system, which is an important component of the immune system. The anticomplement activity exhibited by this compound may be due to its ability to inhibit enzyme activities involved in the formation of the C3 convertase. Ganoderiol F has been shown to have short-term exposure effects on human cells in culture. In particular, it has been shown to have a cytotoxic effect on K562 leukemia cells and induce apoptosis in RAW 264.7 macrophages following stimulation with lipopolysaccharide (LPS). Ganoderiol F also showed a cytotoxic effect against cancer cells in a liquid chromatograph analysis with ganoderic acid as an internal standard. This compound

Ganoderiol F has anti-inflammatory, cytotoxic and anti-HIV activity, it inhibits activity of topoisomerases in vitro, and it inhibits human immunodeficiency